Cargando…

CCNI2 plays a promoting role in the progression of colorectal cancer

Colorectal cancer (CRC) is one of the most common malignancies and most of the patients diagnosed with advanced CRC have unsatisfactory treatment effect and poor prognosis. The purpose of this study was to investigate the effect of CCNI2 on the development of CRC. In this sutdy, immunohistochemical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Dong‐Ming, Bi, Jiang‐Jiang, Chen, Yong‐Hui, Wu, Yu‐Di, Huang, Qing‐Wen, Li, Hai‐Jie, Zhang, Sheng, Fu, Zheng, Tong, Yi‐Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957193/ https://www.ncbi.nlm.nih.gov/pubmed/33620152 http://dx.doi.org/10.1002/cam4.3504

Ejemplares similares

CCNI2 promotes the progression of human gastric cancer through HDGF
por: Chen, Wenchao, et al.
Publicado: (2021)

CCNYL1, but Not CCNY, Cooperates with CDK16 to Regulate Spermatogenesis in Mouse
por: Zi, Zhenzhen, et al.
Publicado: (2015)

The Candidate IBD Risk Gene CCNY Is Dispensable for Intestinal Epithelial Homeostasis
por: Molinas, Andrea, et al.
Publicado: (2021)

LncRNA TUG1 promotes the progression of colorectal cancer via the miR-138-5p/ZEB2 axis
por: Yan, Zhenkun, et al.
Publicado: (2020)

Correction: CCNYL1, but Not CCNY, Cooperates with CDK16 to Regulate Spermatogenesis in Mouse
por: Zi, Zhenzhen, et al.
Publicado: (2019)

HCK promotes glioblastoma progression by TGFβ signaling
por: Wang, Zhenlin, et al.
Publicado: (2020)

CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer
por: Zhang, Xiao‐Guang, et al.
Publicado: (2018)

IBSP, a potential recurrence biomarker, promotes the progression of colorectal cancer via Fyn/β‐catenin signaling pathway
por: Chen, Yan, et al.
Publicado: (2021)

CCNY Accelerates Cylcin E Expression to Regulate the Proliferation of Laryngeal Carcinoma Cells via MEK/ERK Signaling Pathway
por: Zhao, Xiaoting, et al.
Publicado: (2020)

IKKα plays a major role in canonical NF-κB signalling in colorectal cells
por: Prescott, Jack A., et al.
Publicado: (2022)

Prognostic significance of nomograms integrating IL‐37 expression, neutrophil level, and MMR status in patients with colorectal cancer
por: Zhu, Bing, et al.
Publicado: (2018)

Colorectal cancer (CRC) as a multifactorial disease and its causal correlations with multiple signaling pathways
por: Wan, Mao-lin, et al.
Publicado: (2020)

Cooperation of SRPK2, Numb and p53 in the malignant biology and chemosensitivity of colorectal cancer
por: Wang, Guosen, et al.
Publicado: (2020)

The overexpression of AUF1 in colorectal cancer predicts a poor prognosis and promotes cancer progression by activating ERK and AKT pathways
por: Tian, Xin‐Yuan, et al.
Publicado: (2020)

Establishing a detection method for CCNY: a potentially significant clinical investigative marker in NSCLC patients
por: Ma, Li, et al.
Publicado: (2019)

Phosphoregulation of the oncogenic protein regulator of cytokinesis 1 (PRC1) by the atypical CDK16/CCNY complex
por: Hernández-Ortega, Sara, et al.
Publicado: (2019)

Isolation of cancer‐associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma
por: Sha, Meng, et al.
Publicado: (2018)

Predictive impact of the inflammation‐based indices in colorectal cancer patients with adjuvant chemotherapy
por: Tao, Yong, et al.
Publicado: (2018)

MiR-940 promotes malignant progression of breast cancer by regulating FOXO3
por: Zhang, Huayao, et al.
Publicado: (2020)

Cancer‐associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer
por: Aizawa, Takashi, et al.
Publicado: (2019)

Development and validation of a nomogram based on stromal score to predict progression‐free survival of patients with papillary thyroid carcinoma
por: Tang, Jiajia, et al.
Publicado: (2021)

Lack of association between miR-146a rs2910164 C/G locus and colorectal cancer: from a case–control study to a meta-analysis
por: Jiang, Jiakai, et al.
Publicado: (2021)

Nuclear division cycle 80 promotes malignant progression and predicts clinical outcome in colorectal cancer
por: Yan, Xuebing, et al.
Publicado: (2018)

Transforming growth factor-β(1) induces connective tissue growth factor expression and promotes peritoneal metastasis of gastric cancer
por: Lv, Ling, et al.
Publicado: (2020)

Stimulation of hypothalamic oxytocin neurons suppresses colorectal cancer progression in mice
por: Pan, Susu, et al.
Publicado: (2021)

Time‐dependent and nonlinear effects of prognostic factors in nonmetastatic colorectal cancer
por: Chi, Sheng‐Qiang, et al.
Publicado: (2017)

Does marital status impact postoperative survival in patients with less differentiated hepatocellular carcinoma? A population‐based study
por: Yan, Bing, et al.
Publicado: (2019)

AFAP1L1, a novel associating partner with vinculin, modulates cellular morphology and motility, and promotes the progression of colorectal cancers
por: Takahashi, Ryo, et al.
Publicado: (2014)

Serum Anti-CCNY Autoantibody Is an Independent Prognosis Indicator for Postoperative Patients with Early-Stage Nonsmall-Cell Lung Carcinoma
por: Ma, Li, et al.
Publicado: (2013)

RAPTOR promotes colorectal cancer proliferation by inducing mTORC1 and upregulating ribosome assembly factor URB1
por: Wang, Tao, et al.
Publicado: (2019)

ANGPTL1, Foxo3a-Sox2, and colorectal cancer metastasis
por: Jiang, Kai, et al.
Publicado: (2022)

SphK1‐driven autophagy potentiates focal adhesion paxillin‐mediated metastasis in colorectal cancer
por: Wu, Jiang‐Ni, et al.
Publicado: (2021)

LINC‐PINT alleviates lung cancer progression via sponging miR‐543 and inducing PTEN
por: Wang, Shu, et al.
Publicado: (2020)

Strategy to targeting the immune resistance and novel therapy in colorectal cancer
por: Gang, Wang, et al.
Publicado: (2018)

A practical nomogram and risk stratification system predicting the cancer‐specific survival for patients with early hepatocellular carcinoma
por: Yan, Bing, et al.
Publicado: (2020)

CircZFR serves as a prognostic marker to promote bladder cancer progression by regulating miR-377/ZEB2 signaling
por: Zhang, Wen-Yuan, et al.
Publicado: (2019)

Fisetin decreases TET1 activity and CCNY/CDK16 promoter 5hmC levels to inhibit the proliferation and invasion of renal cancer stem cell
por: Si, Yibing, et al.
Publicado: (2018)

MiRNA-574-3p inhibits cell progression by directly targeting CCND2 in colorectal cancer
por: Li, Wen-Cui, et al.
Publicado: (2019)

FOLFOX treatment response prediction in metastatic or recurrent colorectal cancer patients via machine learning algorithms
por: Lu, Wei, et al.
Publicado: (2020)

Malic enzyme 2 promotes the progression of hepatocellular carcinoma via increasing triglyceride production
por: Zhang, Shuai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2k0kfko5el4s4ltsbbf7b3b4oj